Rish Pai, MD, PhD (he/him/his)

Mayo Clinic

Poster(s):

• P2121 - Association of Histologic-Endoscopic Response and Long-Term Clinical Outcomes: Results From Phase 2 Mirikizumab Trial in Patients With Moderately-to-Severely Active Crohn’s Disease
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT